FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625512280> ?p ?o ?g. }

• W2625512280 endingPage "365" @default.
• W2625512280 startingPage "355" @default.
• W2625512280 abstract "Olaratumab is a recombinant human monoclonal antibody that binds to platelet-derived growth factor receptor-α (PDGFRα). In a randomized phase II study, olaratumab plus doxorubicin met its predefined primary endpoint for progression-free survival and achieved a highly significant improvement in overall survival versus doxorubicin alone in patients with advanced or metastatic soft tissue sarcoma (STS). In this study, we characterize the pharmacokinetics (PKs) of olaratumab in a cancer patient population. Olaratumab was tested at 15 or 20 mg/kg in four phase II studies (in patients with nonsmall cell lung cancer, glioblastoma multiforme, STS, and gastrointestinal stromal tumors) as a single agent or in combination with chemotherapy. PK sampling was performed to measure olaratumab serum levels. PK data were analyzed by nonlinear mixed-effect modeling techniques using NONMEM®. The PKs of olaratumab were best described by a two-compartment PK model with linear clearance (CL). Patient body weight was found to have a significant effect on both CL and central volume of distribution (V 1), whereas tumor size significantly affected CL. A small subset of patients developed treatment-emergent anti-drug antibodies (TE-ADAs); however, TE-ADAs did not have any effect on CL or PK time course of olaratumab. There was no difference in the PKs of olaratumab between patients who received olaratumab as a single agent or in combination with chemotherapy. The PKs of olaratumab were best described by a model with linear disposition. Patient body weight and tumor size were found to be significant covariates. The PKs of olaratumab were not affected by immunogenicity or chemotherapeutic agents." @default.
• W2625512280 created "2017-06-23" @default.
• W2625512280 creator A5031684939 @default.
• W2625512280 creator A5041019731 @default.
• W2625512280 creator A5043104677 @default.
• W2625512280 creator A5049306094 @default.
• W2625512280 creator A5054635529 @default.
• W2625512280 creator A5078777880 @default.
• W2625512280 creator A5085285055 @default.
• W2625512280 date "2017-06-15" @default.
• W2625512280 modified "2023-10-17" @default.
• W2625512280 title "Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer" @default.
• W2625512280 cites W1555185942 @default.
• W2625512280 cites W1857557482 @default.
• W2625512280 cites W1969371715 @default.
• W2625512280 cites W1970247466 @default.
• W2625512280 cites W1971343062 @default.
• W2625512280 cites W1971644921 @default.
• W2625512280 cites W1993519240 @default.
• W2625512280 cites W1998532042 @default.
• W2625512280 cites W2011964589 @default.
• W2625512280 cites W2020365240 @default.
• W2625512280 cites W2034775283 @default.
• W2625512280 cites W2045478673 @default.
• W2625512280 cites W2058734479 @default.
• W2625512280 cites W2064668598 @default.
• W2625512280 cites W2066865216 @default.
• W2625512280 cites W2067933166 @default.
• W2625512280 cites W2083860653 @default.
• W2625512280 cites W2089879694 @default.
• W2625512280 cites W2147810684 @default.
• W2625512280 cites W2155214429 @default.
• W2625512280 cites W2164977460 @default.
• W2625512280 cites W2183943917 @default.
• W2625512280 cites W2413552560 @default.
• W2625512280 cites W2485566728 @default.
• W2625512280 cites W2550207834 @default.
• W2625512280 cites W28215347 @default.
• W2625512280 doi "https://doi.org/10.1007/s40262-017-0562-0" @default.
• W2625512280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5814542" @default.
• W2625512280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28620891" @default.
• W2625512280 hasPublicationYear "2017" @default.
• W2625512280 type Work @default.
• W2625512280 sameAs 2625512280 @default.
• W2625512280 citedByCount "19" @default.
• W2625512280 countsByYear W26255122802017 @default.
• W2625512280 countsByYear W26255122802018 @default.
• W2625512280 countsByYear W26255122802019 @default.
• W2625512280 countsByYear W26255122802020 @default.
• W2625512280 countsByYear W26255122802021 @default.
• W2625512280 countsByYear W26255122802022 @default.
• W2625512280 countsByYear W26255122802023 @default.
• W2625512280 crossrefType "journal-article" @default.
• W2625512280 hasAuthorship W2625512280A5031684939 @default.
• W2625512280 hasAuthorship W2625512280A5041019731 @default.
• W2625512280 hasAuthorship W2625512280A5043104677 @default.
• W2625512280 hasAuthorship W2625512280A5049306094 @default.
• W2625512280 hasAuthorship W2625512280A5054635529 @default.
• W2625512280 hasAuthorship W2625512280A5078777880 @default.
• W2625512280 hasAuthorship W2625512280A5085285055 @default.
• W2625512280 hasBestOaLocation W26255122801 @default.
• W2625512280 hasConcept C112705442 @default.
• W2625512280 hasConcept C126322002 @default.
• W2625512280 hasConcept C143998085 @default.
• W2625512280 hasConcept C2776239304 @default.
• W2625512280 hasConcept C2776694085 @default.
• W2625512280 hasConcept C2781303535 @default.
• W2625512280 hasConcept C2908647359 @default.
• W2625512280 hasConcept C71924100 @default.
• W2625512280 hasConcept C98274493 @default.
• W2625512280 hasConcept C99454951 @default.
• W2625512280 hasConceptScore W2625512280C112705442 @default.
• W2625512280 hasConceptScore W2625512280C126322002 @default.
• W2625512280 hasConceptScore W2625512280C143998085 @default.
• W2625512280 hasConceptScore W2625512280C2776239304 @default.
• W2625512280 hasConceptScore W2625512280C2776694085 @default.
• W2625512280 hasConceptScore W2625512280C2781303535 @default.
• W2625512280 hasConceptScore W2625512280C2908647359 @default.
• W2625512280 hasConceptScore W2625512280C71924100 @default.
• W2625512280 hasConceptScore W2625512280C98274493 @default.
• W2625512280 hasConceptScore W2625512280C99454951 @default.
• W2625512280 hasFunder F4320307758 @default.
• W2625512280 hasIssue "3" @default.
• W2625512280 hasLocation W26255122801 @default.
• W2625512280 hasLocation W26255122802 @default.
• W2625512280 hasLocation W26255122803 @default.
• W2625512280 hasLocation W26255122804 @default.
• W2625512280 hasOpenAccess W2625512280 @default.
• W2625512280 hasPrimaryLocation W26255122801 @default.
• W2625512280 hasRelatedWork W1499958231 @default.
• W2625512280 hasRelatedWork W1987705191 @default.
• W2625512280 hasRelatedWork W2020252702 @default.
• W2625512280 hasRelatedWork W2067689242 @default.
• W2625512280 hasRelatedWork W2087821742 @default.
• W2625512280 hasRelatedWork W2090892185 @default.
• W2625512280 hasRelatedWork W2165824272 @default.
• W2625512280 hasRelatedWork W2754839811 @default.
• W2625512280 hasRelatedWork W2982147588 @default.

• next